·
Our team is investigating the genetic underpinnings of rare diseases to develop targeted therapies. By utilizing advanced genomic sequencing techniques, we aim to identify specific mutations and their impacts on patient health. This project not only seeks to enhance our understanding of these complex conditions but also to provide tailored treatment options that can significantly improve patient outcomes.